Correlation Analysis
Meta Platforms, Inc. Class A Common Stock vs Incyte Genomics Inc
META vs INCY
+0.192
Weak positive
When one moves up, the other tends to follow.
Meta Platforms, Inc. Class A Common Stock
↗META
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
Market cap 1.4T
Incyte Genomics Inc
↗INCY
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
Market cap 18.9B · 2,844 employees
Time Series
Relative Performance
Who Moves First
META leads INCY by 6 days
META tends to move before INCY.
After testing 13 timing shifts, the strongest relationship was +0.214 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.312
13 periods · Return correlation when both series rose
Both Falling
+0.343
7 periods · Return correlation when both series fell
Diverging
-0.689
15 periods · Return correlation when series moved apart
R-Squared
3.7%
Share of variance in one series explained by the other.
Trend Agreement
56.0%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,107
Deep shared window — 1,107 usable pairs.
Significance
p < 0.001
95% CI: [0.134, 0.248]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,107 paired data points survived the daily window.
Raw input
1,107
1,254
Normalized
1,107
1,254
Prepared
1,107
1,254
Aligned
1,107
1,107
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
147
A: 0 / B: 147
Series A
Meta Platforms, Inc. Class A Common Stock
META
Market cap 1.4T
Stock · 1,107 raw → 1,107 prepared
Series B
Incyte Genomics Inc
INCY
Market cap 18.9B · 2,844 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
1
Estimated crossover points between normalized spreads.
Slope
0.0100
Linear regression slope.
Intercept
67.9911
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
META
Meta Platforms, Inc. Class A Common Stock
Highest
+0.979
PCEC96
PCEC96 · 52 data points
Lowest
-0.939
United Parcel Service, Inc. Class B
UPS · 1,107 data points
Saved 5 hours ago · ID: stock-meta-vs-stock-incy-daily-20260408-x9j94z